IIL.GSE INTRAVENOUS INFUSIONS LIMITED
Company Analysis
Latest News
🔴 Intravenous Infusions is trading 5% down
Intravenous Infusions is trading at GHS 0.54, down 5.26%, with no clear company-specific catalyst identified. - On October 26, the company discussed plans to...
🔴 Intravenous Infusions is trading 3.45% down with no confirmed company-specific catalyst
Intravenous Infusions is trading at GHS 0.56, down -3.45%, against a backdrop of broader Ghana-market weakness; no company-specific announcement explaining the...
🔴 Intravenous Infusions is trading 3.28% down; no confirmed catalyst identified
Intravenous Infusions is trading at GHS 0.59, down 3.28% on October 21, 2026, with no confirmed catalyst identified. - No verified company-specific...
🔴 Intravenous Infusions is trading 3.17% down; no verified company-specific cause
Intravenous Infusions is trading at GHS 0.61, down 3.17%, with no verified company-specific announcement explaining the decline. - The company website lists an...
🟢 Intravenous Infusions is trading 5% up today amid Ghana's 1.59% composite-index rise
Intravenous Infusions is trading at GHS 0.63, up 5.00%; no verified company-specific announcement was found to explain the gain. - The Ghana Stock Exchange...
🟢 Intravenous Infusions is trading 7.27% up — catalyst remains unclear
Intravenous Infusions is trading at GHS 0.59, up 7.27%, with no clear company-specific explanation identified for the move. - The company’s website lists an...
🟢 Intravenous Infusions is trading 7.84% up
Intravenous Infusions is trading at GHS 0.55, up 7.84%, with no company-specific announcement found to explain the move on October 13, 2026. - The Ghana Stock...
🔴 Intravenous Infusions is trading 7.27% down
Intravenous Infusions is trading 7.27% down at GHS 0.51, with no clear company-specific catalyst identified. - The last completed session was October 9; the...
🟢 Intravenous Infusions is trading 3.77% up on October 8, 2026 with no identified catalyst
Intravenous Infusions is trading at GHS 0.55, up 3.77% on October 8, 2026; no specific company news has been identified to explain the rise. - The Ghana Stock...
🟢 Intravenous Infusions is trading 8.16% up
Intravenous Infusions is trading 8.16% up at GHS 0.53, with no clearly linked catalyst identified for the October 7, 2026 move. - The latest located market...
🔴 Intravenous Infusions is trading 7.6% down
Intravenous Infusions is trading 7.6% down at GHS 0.49, with no company-specific announcement or clearly linked catalyst identified for the October 6, 2026...
🟢 Intravenous Infusions is trading 3.9% up
Intravenous Infusions is trading at GHS 0.53, up 3.92%, with no verified catalyst identified in the September 30, 2026 price context. - No company-specific...
🔴 Intravenous Infusions is trading 5.66% down today with no clear catalyst identified
Intravenous Infusions is trading 5.66% down at GHS 0.50, with no clear company-specific announcement or fresh catalyst identified for September 25, 2026. -...
🔴 Intravenous Infusions is trading 3.57% down today — catalyst remains unclear
Intravenous Infusions is trading 3.57% down now at $0.54 based on supplied price context for September 17, 2026, with no credible company-specific announcement...
🟢 Intravenous Infusions is trading 3.64% up today amid defensive healthcare-sector rotation
Intravenous Infusions is trading 3.64% up at GHS 0.57, most likely reflecting active healthcare-sector rotation toward defensive assets as broader markets...
🔴 Intravenous Infusions is trading 3.51% down today
Intravenous Infusions is trading at GHS 0.55 (-3.51%) amid continued selling pressure following consecutive declines through September 9, 2026. - No...
🔴 Intravenous Infusions is trading 5% down today; no specific catalyst identified
Intravenous Infusions is trading 5% down at GHS 0.57 after another weak session on September 9, 2026; no company-specific catalyst has been identified. - No...
🔴 Intravenous Infusions is trading 7.69% down today as no company-specific catalyst is confirmed
Intravenous Infusions is trading 7.69% down now at GHS 0.60, with no confirmed company-specific catalyst identified for the September 9 decline. - The stock...
🔴 Intravenous Infusions is trading 5.80% down today with no confirmed catalyst
Intravenous Infusions is trading 5.80% down at GHS 0.65, with no confirmed company-specific announcement or event identified for September 8, 2026. - Recent...
🔴 Intravenous Infusions is trading 4.17% down with no confirmed catalyst
Intravenous Infusions is trading at GHS 0.69, down 4.17%, with no confirmed company-specific catalyst. - The September 4, 2026 decline remains unexplained in...